Consolidated Statements of Operations and Comprehensive Income / (Loss) - USD ($) |
3 Months Ended | 12 Months Ended | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
Mar. 31, 2020 |
Dec. 31, 2019 |
Sep. 30, 2019 |
Jun. 30, 2019 |
Mar. 31, 2019 |
Dec. 31, 2018 |
Sep. 30, 2018 |
Jun. 30, 2018 |
Mar. 31, 2020 |
Mar. 31, 2019 |
Mar. 31, 2018 |
|
| Income Statement [Abstract] | |||||||||||
| Net revenues | $ 39,351,000 | $ 36,016,000 | $ 32,795,000 | $ 30,553,000 | $ 27,192,000 | $ 30,411,000 | $ 23,854,000 | $ 22,112,000 | $ 138,715,000 | $ 103,569,000 | $ 74,751,000 |
| Costs of revenues | |||||||||||
| License fees and revenue share | 23,591,000 | 21,576,000 | 20,146,000 | 18,275,000 | 15,768,000 | 19,195,000 | 15,802,000 | 15,216,000 | 83,588,000 | 65,981,000 | 47,967,000 |
| Other direct costs of revenues | 432,000 | 400,000 | 344,000 | 278,000 | 470,000 | 538,000 | 508,000 | 507,000 | 1,454,000 | 2,023,000 | 1,729,000 |
| Total cost of revenues | 85,042,000 | 68,004,000 | 49,696,000 | ||||||||
| Gross profit | 15,328,000 | 14,040,000 | 12,305,000 | 12,000,000 | 10,954,000 | 10,678,000 | 7,544,000 | 6,389,000 | 53,673,000 | 35,565,000 | 25,055,000 |
| Operating expenses | |||||||||||
| Product development | 12,018,000 | 10,876,000 | 9,653,000 | ||||||||
| Sales and marketing | 11,244,000 | 8,212,000 | 6,087,000 | ||||||||
| General and administrative | 17,199,000 | 13,032,000 | 15,124,000 | ||||||||
| Total operating expenses | 12,403,000 | 9,908,000 | 9,190,000 | 8,960,000 | 9,020,000 | 8,222,000 | 7,229,000 | 7,649,000 | 40,461,000 | 32,120,000 | 30,864,000 |
| Income / (loss) from operations | 2,925,000 | 4,132,000 | 3,115,000 | 3,040,000 | 1,934,000 | 2,456,000 | 315,000 | (1,260,000) | 13,212,000 | 3,445,000 | (5,809,000) |
| Interest and other income / (expense), net | |||||||||||
| Interest income / (expense) | 41,000 | (1,120,000) | (2,067,000) | ||||||||
| Foreign exchange transaction gain / (loss) | 0 | 3,000 | (148,000) | ||||||||
| Change in fair value of convertible note embedded derivative liability | 0 | (1,008,000) | (7,559,000) | ||||||||
| Change in fair value of warrant liability | (9,580,000) | (4,875,000) | (3,208,000) | ||||||||
| Loss on extinguishment of debt | 0 | (431,000) | (1,785,000) | ||||||||
| Other income / (expense) | 232,000 | 153,000 | (72,000) | ||||||||
| Total interest and other income / (expense), net | 721,000 | (830,000) | (4,380,000) | (4,818,000) | (8,384,000) | (3,376,000) | 1,730,000 | 2,752,000 | (9,307,000) | (7,278,000) | (14,839,000) |
| Income / (loss) from continuing operations before income taxes | 3,646,000 | 3,302,000 | (1,265,000) | (1,778,000) | (6,450,000) | (920,000) | 2,045,000 | 1,492,000 | 3,905,000 | (3,833,000) | (20,648,000) |
| Income tax (benefit) / provision | (10,375,000) | 469,000 | (951,000) | ||||||||
| Income / (loss) from continuing operations, net of taxes | $ 14,027,000 | $ 3,261,000 | $ (1,337,000) | $ (1,671,000) | $ (6,762,000) | $ (1,136,000) | $ 2,068,000 | $ 1,528,000 | 14,280,000 | (4,302,000) | (19,697,000) |
| Loss from discontinued operations | (380,000) | (1,708,000) | (33,160,000) | ||||||||
| Loss from discontinued operations, net of taxes | (380,000) | (1,708,000) | (33,160,000) | ||||||||
| Net income / (loss) | 13,900,000 | (6,010,000) | (52,857,000) | ||||||||
| Other comprehensive loss | |||||||||||
| Foreign currency translation adjustment | (235,000) | (31,000) | (4,000) | ||||||||
| Comprehensive income / (loss) | $ 13,665,000 | $ (6,041,000) | $ (52,861,000) | ||||||||
| Basic net income / (loss) per common share | |||||||||||
| Continuing operations (in dollars per share) | $ 0.17 | $ (0.06) | $ (0.28) | ||||||||
| Discontinued operations (in dollars per share) | 0.00 | (0.02) | (0.47) | ||||||||
| Basic net income / (loss) per common share (in dollars per share) | $ 0.17 | $ (0.08) | $ (0.75) | ||||||||
| Weighted-average common shares outstanding, basic | 86,784,000 | 85,876,000 | 83,909,000 | 81,814,000 | 79,404,000 | 77,645,000 | 77,193,000 | 76,204,000 | 84,594,000 | 77,440,000 | 70,263,000 |
| Diluted net income / (loss) per common share | |||||||||||
| Continuing operations (in dollars per share) | $ 0.16 | $ (0.06) | $ (0.28) | ||||||||
| Discontinued operations (in dollars per share) | 0.00 | (0.02) | (0.47) | ||||||||
| Diluted net income / (loss) per common share (in dollars per share) | $ 0.16 | $ (0.08) | $ (0.75) | ||||||||
| Weighted-average common shares outstanding, diluted | 91,875,000 | 92,472,000 | 83,909,000 | 81,814,000 | 79,404,000 | 77,645,000 | 78,780,000 | 79,598,000 | 89,558,000 | 77,440,000.00 | 70,263,000 |
| X | ||||||||||
- Definition Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income, attributable to parent entity. Excludes changes in equity resulting from investments by owners and distributions to owners. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition The aggregate costs related to goods produced and sold and services rendered by an entity during the reporting period. This excludes costs incurred during the reporting period related to financial services rendered and other revenue generating activities. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition The aggregate cost of goods produced and sold and services rendered during the reporting period. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- Definition Amount before tax of income (loss) from a discontinued operation. Includes, but is not limited to, the income (loss) from operations during the phase-out period, gain (loss) on disposal, gain (loss) for reversal of write-down (write-down) to fair value, less cost to sell, and adjustments to a prior period gain (loss) on disposal. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- Definition The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period. Reference 1: http://www.xbrl.org/2003/role/exampleRef
|
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- Definition Amount of expense (income) related to adjustment to fair value of warrant liability. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Amount before tax of foreign currency transaction realized and unrealized gain (loss) recognized in the income statement. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Aggregate net gain (loss) on all derivative instruments recognized in earnings during the period, before tax effects. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Difference between the fair value of payments made and the carrying amount of debt which is extinguished prior to maturity. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition The aggregate total of expenses of managing and administering the affairs of an entity, including affiliates of the reporting entity, which are not directly or indirectly associated with the manufacture, sale or creation of a product or product line. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Aggregate revenue less cost of goods and services sold or operating expenses directly attributable to the revenue generation activity. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Amount after tax of income (loss) from continuing operations attributable to the parent. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Amount of income (loss) from continuing operations before deduction of income tax expense (benefit) and income (loss) attributable to noncontrolling interest, and addition of income (loss) from equity method investments. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition The amount of net income (loss) from continuing operations per each share of common stock or unit outstanding during the reporting period. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition The amount of net income (loss) derived from continuing operations during the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Amount after tax of income (loss) from a discontinued operation attributable to the parent. Includes, but is not limited to, the income (loss) from operations during the phase-out period, gain (loss) on disposal, gain (loss) for reversal of write-down (write-down) to fair value, less cost to sell, and adjustments to a prior period gain (loss) on disposal. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Per basic share amount, after tax, of income (loss) from the day-to-day business activities of the discontinued operation and gain (loss) from the disposal of the discontinued operation. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Per diluted share amount, after tax, of income (loss) from the day-to-day business activities of the discontinued operation and gain (loss) from the disposal of the discontinued operation. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- Definition Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition The net amount of operating interest income (expense). Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition The portion of profit or loss for the period, net of income taxes, which is attributable to the parent. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business). Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- Definition Generally recurring costs associated with normal operations except for the portion of these expenses which can be clearly related to production and included in cost of sales or services. Includes selling, general and administrative expense. No definition available.
|
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- Definition The net result for the period of deducting operating expenses from operating revenues. No definition available.
|
| X | ||||||||||
- Definition Amount after tax and reclassification adjustments of gain (loss) on foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- Definition Other costs incurred during the reporting period related to other revenue generating activities. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Amount of income (expense) related to nonoperating activities, classified as other. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition The aggregate costs incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process whether intended for sale or the entity's use, during the reporting period charged to research and development projects, including the costs of developing computer software up to the point in time of achieving technological feasibility, and costs allocated in accounting for a business combination to in-process projects deemed to have no alternative future use. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition The aggregate total amount of expenses directly related to the marketing or selling of products or services. No definition available.
|
| X | ||||||||||
- Definition The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|